Jun 272025 Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed.
